The Ajanta Pharma Limited date has been confirmed from June 5, 2024 – June 11, 2024.
Incorporated in December 1979, Ajanta Pharma Limited develops, manufactures and markets speciality pharmaceutical formulations. The Company has seven manufacturing facilities in India, two of which have been approved by the US FDA. Additionally, the Company has a research and development centre for active pharmaceutical ingredient synthesis and finished formulations.
Start your investing journey today. Find the latest information on Buybacks.
Key Details Of Ajanta Pharma Limited
Bidding Dates
June 5-11
Buyback Price
₹2770 per share
Face Value
₹2 per share
Offer Closes On
June 11, 2024
Ajanta Pharma Limited IPO Buyback Price
The Ajanta Pharma Limited Buyback Price is ₹2770 per share.
IPO Overview
The Company has seven manufacturing facilities in India, two of which have been approved by the US FDA. Additionally, the Company has a research and development centre for active pharmaceutical ingredient synthesis and finished formulations.
Our commitment to addressing patient needs drives us to create unique first-to-market products. This innovative product lineup helps us lead in different molecule and therapeutic categories.
Ajanta Pharma Limited Buyback Detail
| Issue Period | June 5, 2024 – June 11, 2024 |
| Security Name | Ajanta Pharma Limited |
| Issue Type | Tender Offer |
| Issue Size (Shares) | 1,028,881 (0.82 % of Total number of equity Shares) |
| Issue Size (Amount) | ₹285.00 Crores |
| Buyback Price | ₹2770 per share |
| Face Value | ₹2 per share |
| Listing At | BSE, NSE |
Ajanta Pharma Limited Financial Information
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 4,638.39 | 4,679.02 | |
| Revenue | 4,293.31 | 3,841.28 | 3,456.67 |
| Profit After Tax | 816.17 | 587.98 | 712.68 |
| Amount in ₹ Crore | |||
Ajanta Pharma Limited Buyback Issue Timetable
| Last Date to buy shares | May 29, 2024 |
| Record Date | May 30, 2024 |
| Offer Opens On | June 5, 2024 |
| Last Date for receipt of Tender Forms | June 11, 2024 |
| Offer Closes On * | June 11, 2024 |
| Finalisation of Buyback Acceptance | June 18, 2024 |
| Last Date for settlment of bids | June 19, 2024 |
| Last Date for Extinguishment of Shares | June 28, 2024 |
Company Profile
We have a deep understanding of what our customers need and we utilize advanced technology to offer creative solutions. Our business covers Branded Generics in India and Emerging Markets in Asia and Africa, Generics in the USA, and Institution Sales in Africa. Our diverse sources of revenue make our business model flexible and long-lasting.Buyback is being undertaken, inter-alia, for the following reasons:
- The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares broadly in
proportion to their shareholding, thereby, enhancing the overall return to shareholders
- The Buyback will follow the tender offer route as per SEBI Buyback Regulations. It will allocate Equity Shares based on entitlement or 15% of the total shares to be bought back, whichever is higher, for small shareholders. This reservation aims to benefit a significant number of public shareholders classified as “small shareholders” under Regulation 2(i)(n) of the SEBI Buyback Regulations.
- The Buyback can enhance its earnings per share and return on equity by reducing the equity base. This will ultimately result in a long-term boost in shareholders’ value.
Registrar Info
| Name | Link Intime India Private Ltd |
| Phone number | +91-22-4918 6270 |
| Email ID | [email protected] |
| Website | linkintime.co.in |
Contact Details
| Name | Ajanta Pharma Limited |
| Phone number | +91 22 6606 1000 |
| Email ID | [email protected] |
| Website | ajantapharma.com |
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Ajanta Pharma Limited IPO FAQs
Which is the last day to buy Ajanta Pharma Buyback 2024 for buyback?
Last date to be eligible to participate in buyback is May 29, 2024.
What is the schedule of activities for Ajanta Pharma Buyback 2024?
Sorry the Ajanta Pharma Buyback 2024 timelines are not available at this time.
What is the record date for Ajanta Pharma Buyback 2024 offer?
The record date for the Ajanta Pharma Buyback 2024 is May 30, 2024.
